A new report by Express Scripts, Inc. found that U.S. consumers could have saved $20 billion in 2004 by using more generic drugs, with the most dramatic savings potential existing for generic gastrointestinals and anti-cholesterol medications.
The Georgia Medicaid program implemented a prior-authorization program for anti-ulcer drugs, resulting in a net savings of $20.6 million. The program increased the use of generic histamine type-2 antagonists and decreased PPI drug expenditures by $30.9 million.
A study published by Express Scripts found that pharmacy dose consolidation programs offer minimal cost savings, ranging from $0.02 to $0.03 per member per month. The program's effectiveness was limited due to the low number of prescriptions and the availability of generic or over-the-counter options.
A recent study by Express Scripts reveals a significant surge in Viagra use among younger men, with increases of 312% and 216% among those aged 18-45 and 46-55 years respectively. Meanwhile, growth in use slowed among women and older men, highlighting concerns over the coverage of lifestyle medications like Viagra.
Researchers found that over half of COX-2 patients take aspirin, leading to a loss of GI protective effects and increased risk of bleeding. Patients should consider alternative NSAIDs or proton pump inhibitors for added protection.
A study by Express Scripts found that antidepressant use increased significantly among children and adolescents between 1998 and 2002. The fastest-growing segment was preschoolers aged 0-5 years, with use doubling in girls and growing by 64% in boys.
Researchers at Express Scripts found that COX-2 prescribing physicians often co-prescribe gastroprotective drugs, contradicting expert estimates. This challenges the use of expert opinion in estimating practice pattern model inputs and warrants re-evaluation of COX-2 cost-effectiveness models.